Lausanne (Switzerland)
Aseptic and Low Bioburden Processes : Control, Innovation and Compliance with Annex 1
The EU GMP Annex 1 places contamination control and aseptic process performance at the forefront of pharmaceutical manufacturing priorities. The A3P Congress 2026 will dedicate two full days to aseptic and low bioburden processes, bringing together experts, industry leaders and regulatory representatives to discuss compliance, innovation and operational excellence.
Veranstaltungsdaten
Lausanne (Switzerland)
Beau-Rivage Palace